GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orient Pharma Co Ltd (ROCO:4166) » Definitions » Scaled Net Operating Assets

Orient Pharma Co (ROCO:4166) Scaled Net Operating Assets : 0.88 (As of Jun. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Orient Pharma Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Orient Pharma Co's operating assets for the quarter that ended in Jun. 2024 was NT$2,422 Mil. Orient Pharma Co's operating liabilities for the quarter that ended in Jun. 2024 was NT$169 Mil. Orient Pharma Co's Total Assets for the quarter that ended in Dec. 2023 was NT$2,563 Mil. Therefore, Orient Pharma Co's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.88.


Orient Pharma Co Scaled Net Operating Assets Historical Data

The historical data trend for Orient Pharma Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orient Pharma Co Scaled Net Operating Assets Chart

Orient Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 0.86 0.79 0.85 1.23

Orient Pharma Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.87 1.23 0.89 0.88

Competitive Comparison of Orient Pharma Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Orient Pharma Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orient Pharma Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orient Pharma Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Orient Pharma Co's Scaled Net Operating Assets falls into.



Orient Pharma Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Orient Pharma Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(2449.555-175.255)/1847.577
=1.23

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2562.674 - 113.119
=2449.555

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=892.182 - 323.734 - 393.193
=175.255

Orient Pharma Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jun. 2024 )
=(Operating Assets (Q: Jun. 2024 )-Operating Liabilities (Q: Jun. 2024 ))/Total Assets (Q: Dec. 2023 )
=(2421.947-169.493)/2562.674
=0.88

where

Operating Assets(Q: Jun. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2602.491 - 180.544
=2421.947

Operating Liabilities(Q: Jun. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=831.376 - 265.452 - 396.431
=169.493

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orient Pharma Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Orient Pharma Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Orient Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Kehu 1st Road, Huwei Town, Yunlin County, Central Science Park, Taipei, TWN, 106
Orient Pharma Co Ltd develops and manufactures pharmaceuticals. The company uses its platform technologies for the development of specialty pharmaceutical products and is capable of manufacturing products under cGMP. It provides drugs for treating Alzheimer's disease, psychostimulants, and treating Parkinson's disease.

Orient Pharma Co Headlines

No Headlines